239 related articles for article (PubMed ID: 2548708)
1. Immunological and pharmacological removal of small cell lung cancer cells from bone marrow autografts.
Humblet Y; Feyens AM; Sekhavat M; Agaliotis D; Canon JL; Symann ML
Cancer Res; 1989 Sep; 49(18):5058-61. PubMed ID: 2548708
[TBL] [Abstract][Full Text] [Related]
2. Elimination of small cell lung cancer cells in vitro from human bone marrow by a monoclonal antibody.
Okabe T; Kaizu T; Ozawa K; Urabe A; Takaku F
Cancer Res; 1985 May; 45(5):1930-3. PubMed ID: 2985239
[TBL] [Abstract][Full Text] [Related]
3. Purging of small cell lung cancer cells from human bone marrow using ethiofos (WR-2721) and light-activated merocyanine 540 phototreatment.
Meagher RC; Rothman SA; Paul P; Koberna P; Willmer C; Baucco PA
Cancer Res; 1989 Jul; 49(13):3637-41. PubMed ID: 2543500
[TBL] [Abstract][Full Text] [Related]
4. Elimination of malignant clonogenic breast cancer cells from human bone marrow.
Anderson IC; Shpall EJ; Leslie DS; Nustad K; Ugelstad J; Peters WP; Bast RC
Cancer Res; 1989 Aug; 49(16):4659-64. PubMed ID: 2663144
[TBL] [Abstract][Full Text] [Related]
5. Effective purging of bone marrow by a combination of immunorosette depletion and complement lysis.
Slaper-Cortenbach IC; Admiraal LG; van Leeuwen EF; Kerr JM; von dem Borne AE; Tetteroo PA
Exp Hematol; 1990 Jan; 18(1):49-54. PubMed ID: 2298269
[TBL] [Abstract][Full Text] [Related]
6. Elimination of clonogenic tumor cells from human bone marrow using a combination of monoclonal antibody:ricin A chain conjugates.
Bregni M; De Fabritiis P; Raso V; Greenberger J; Lipton J; Nadler L; Rothstein L; Ritz J; Bast RC
Cancer Res; 1986 Mar; 46(3):1208-13. PubMed ID: 3510720
[TBL] [Abstract][Full Text] [Related]
7. Purging of small cell lung cancer-contaminated bone marrow by monoclonal antibodies and magnetic beads.
Elias AD; Pap SA; Bernal SD
Prog Clin Biol Res; 1990; 333():263-75. PubMed ID: 2155434
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of a combined treatment with ASTA-Z 7654 and VP16-213 in vitro in eradicating clonogenic tumor cells from human bone marrow.
De Fabritiis P; Pulsoni A; Sandrelli A; Simone F; Amadori S; Meloni G; Mandelli F
Bone Marrow Transplant; 1987 Oct; 2(3):287-98. PubMed ID: 3502785
[TBL] [Abstract][Full Text] [Related]
9. Elimination of small cell carcinoma of the lung from human bone marrow by monoclonal antibodies and immunomagnetic beads.
Vredenburgh JJ; Ball ED
Cancer Res; 1990 Nov; 50(22):7216-20. PubMed ID: 2171759
[TBL] [Abstract][Full Text] [Related]
10. Eradication of small cell lung cancer cells from human bone marrow with immunotoxins.
Myklebust AT; Godal A; Pharo A; Juell S; Fodstad O
Cancer Res; 1993 Aug; 53(16):3784-8. PubMed ID: 8393381
[TBL] [Abstract][Full Text] [Related]
11. [Application of monoclonal antibodies to diagnosis and treatment of small cell lung cancers].
Fujisawa M; Okabe T
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):984-9. PubMed ID: 2839119
[TBL] [Abstract][Full Text] [Related]
12. Selective cytotoxicity of the SM1 monoclonal antibody towards small cell carcinoma of the lung.
Bernal SD; Mabry M; Stahel RA; Griffin JD; Speak JA
Cancer Res; 1985 Mar; 45(3):1026-32. PubMed ID: 2982482
[TBL] [Abstract][Full Text] [Related]
13. Preclinical studies of the combination of mafosfamide (Asta-Z 7654) and etoposide (VP-16-213) for purging leukemic autologous marrow.
Tamayo E; Hervé P
Exp Hematol; 1988 Feb; 16(2):97-101. PubMed ID: 3276544
[TBL] [Abstract][Full Text] [Related]
14. Separation of clonogenic tumor cells from small cell lung cancer bone marrow and small cell lung cancer cell lines.
Gordon LI; Rosen ST; Vriesendorp HM; Kies MS; Kucuk O
Cancer Res; 1984 Nov; 44(11):5404-8. PubMed ID: 6091877
[TBL] [Abstract][Full Text] [Related]
15. Combined ex vivo treatment with immunotoxins and mafosfamid: a novel immunochemotherapeutic approach for elimination of neoplastic T cells from autologous marrow grafts.
Uckun FM; Stong RC; Youle RJ; Vallera DA
J Immunol; 1985 May; 134(5):3504-15. PubMed ID: 3884712
[TBL] [Abstract][Full Text] [Related]
16. Selective depletion of human myeloma clonogenic stem cells from bone marrow cell preparations by a plasma-cell reactive antibody and complement.
Stone MJ; Tong AW; Fay JW; Lee JC
Cancer Detect Prev; 1988; 12(1-6):621-35. PubMed ID: 3180147
[TBL] [Abstract][Full Text] [Related]
17. Pre-clinical evaluation of anti-lacto-N-fucopentaose III (CD15) monoclonal antibodies for ex vivo bone marrow purging in acute myeloid leukemia.
Guyotat D; Shi ZH; Campos L; Rabat M; Bonnier S; Poncelet P; Laurent JC; Fiere D
Bone Marrow Transplant; 1990 Dec; 6(6):385-90. PubMed ID: 1982926
[TBL] [Abstract][Full Text] [Related]
18. Elimination of malignant clonogenic cells from human bone marrow using multiple monoclonal antibodies and complement.
Bast RC; De Fabritiis P; Lipton J; Gelber R; Maver C; Nadler L; Sallan S; Ritz J
Cancer Res; 1985 Feb; 45(2):499-503. PubMed ID: 3967224
[TBL] [Abstract][Full Text] [Related]
19. Combined chemoseparation and immunoseparation of clonogenic T lymphoma cells from human bone marrow using 2'-deoxycoformycin, deoxyadenosine, 3A1 monoclonal antibody, and complement.
Haleem A; Kurtzberg J; Olsen GA; Rhinehardt-Clark A; Leslie DS; Ray L; Smith CA; Peters WP; Haynes BF; Bast RC
Cancer Res; 1987 Sep; 47(17):4608-12. PubMed ID: 3113721
[TBL] [Abstract][Full Text] [Related]
20. Expression of antigens associated with small cell carcinoma of the lung on hematopoietic progenitor cells.
Ball ED; Keefe KA; Colby E
Cancer Res; 1987 Dec; 47(24 Pt 1):6556-9. PubMed ID: 2824035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
